Gilead Sciences Inc banner

Gilead Sciences Inc
MIL:GILD

Watchlist Manager
Gilead Sciences Inc Logo
Gilead Sciences Inc
MIL:GILD
Watchlist
Price: 68.88 EUR 1.09% Market Closed
Market Cap: €85.9B

Wall St Price Targets

GILD Price Targets Summary
Gilead Sciences Inc

Wall Street analysts forecast GILD stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for GILD is 88.61 EUR with a low forecast of 67.63 EUR and a high forecast of 103.73 EUR.

Lowest Forecast
Price Target
67.63 EUR
2% Downside
Average Forecast
Price Target
88.61 EUR
29% Upside
Highest Forecast
Price Target
103.73 EUR
51% Upside
Gilead Sciences Inc Competitors:
Price Targets
SPEC
Inspecs Group PLC
-28% Downside
INO
Inovio Pharmaceuticals Inc
278% Upside
AREC
American Resources Corp
190% Upside
ZEAL
Zealand Pharma A/S
95% Upside
ZNTL
Zentalis Pharmaceuticals Inc
85% Upside
1981
Cathay Media and Education Group Inc
54% Upside
CREX
Creative Realities Inc
129% Upside

Revenue
Forecast

9% / Year
Past Growth
4% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss
9% / Year
Past Growth
4% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss

Over the last 13 years, the compound annual growth rate for Revenue has been 9%. The projected CAGR for the next 8 years is 4%.

Gross Profit
Forecast

9% / Year
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
9% / Year
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
Gross Profit Forecast
is not available for Gilead Sciences Inc

Operating Income
Forecast

8% / Year
Past Growth
8% / Year
Estimated Growth
Estimates Accuracy
-9%
Average Miss
8% / Year
Past Growth
8% / Year
Estimated Growth
Estimates Accuracy
-9%
Average Miss

Over the last 13 years, the compound annual growth rate for Operating Income has been 8%. The projected CAGR for the next 8 years is 8%.

Pre-Tax Income
Forecast

8% / Year
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
8% / Year
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
Pre-Tax Income Forecast
is not available for Gilead Sciences Inc

Net Income
Forecast

10% / Year
Past Growth
9% / Year
Estimated Growth
Estimates Accuracy
-36%
Average Miss
10% / Year
Past Growth
9% / Year
Estimated Growth
Estimates Accuracy
-36%
Average Miss

Over the last 13 years, the compound annual growth rate for Net Income has been 10%. The projected CAGR for the next 8 years is 9%.

Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is GILD's stock price target?
Price Target
88.61 EUR

According to Wall Street analysts, the average 1-year price target for GILD is 88.61 EUR with a low forecast of 67.63 EUR and a high forecast of 103.73 EUR.

What is the Revenue forecast for Gilead Sciences Inc?
Projected CAGR
4%

Over the last 13 years, the compound annual growth rate for Revenue has been 9%. The projected CAGR for the next 8 years is 4%.

What is the Operating Income forecast for Gilead Sciences Inc?
Projected CAGR
8%

Over the last 13 years, the compound annual growth rate for Operating Income has been 8%. The projected CAGR for the next 8 years is 8%.

What is the Net Income forecast for Gilead Sciences Inc?
Projected CAGR
9%

Over the last 13 years, the compound annual growth rate for Net Income has been 10%. The projected CAGR for the next 8 years is 9%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett